🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Magnesium Sulfate and Postoperative Hypercoagulability in Laparoscopic Gynecological Surgeries

RecruitingNAAges 18 Years - anyFemaleMarianna Mavromati
NCT06717490 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This will be a prospective randomized, double-blind study, aiming at investigating the effects of magnesium sulfate on postoperative hypercoagulability in patients undergoing laparoscopic gynecological surgeries under general anesthesia

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * ASA I and II patients * Laparoscopic gynecological surgeries * age \>18 years * Patients receiving prophylactic anticoagulant therapy 12 hours before surgery based on the Caprini score * Patients receiving prophylactic anticoagulant therapy 12 hours postoperatively based on the Caprini score. Exclusion Criteria: * ASA ≥ III * age \<18 years * BMI \>40 kg/m² * Pregnancy * Known hematologic disorders * Liver/kidney/cardiovascular disease * Severe anemia (6,5- 7,9 g/dl) * Inability or refusal to provide informed consent
💊

What it tests

  • Magnesium sulphate
  • Placebo Drug
📍

Where

1 site
Aretaieion University Hospital
Athens, Greece
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy